Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Serotonin-Deficient Knock-out Mouse
Case ID:
TAB-1514
Web Published:
12/6/2022
Serotonin is an important modulator of many developmental, behavioral, and physiological processes, and it has been implicated in depression, anxiety, schizophrenia, obsessive compulsive disorders, and substance abuse. Serotonin’s pharmacology is extremely complex and it is mediated by seven of serotonin receptor subtypes and it is present in several tissues. Although it has been a subject of a number of studies, its role has been difficult to ascertain. To investigate the role of serotonin in these disorders, the murine gene was disrupted by homologous recombination. Results indicate that serotonin binding sites were absent in different brain regions (brain stem, frontal cortex, hippocampus, and striatum), and its concentrations were reduced by 60-80%. These mice represent a powerful tool for the investigation of behavioral and neuropsychiatric disorders, and development of drug treatments for these disorders.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Serotonin-Deficient_Knock-out_Mouse
Keywords:
AC6XXX
ACXXXX
AXXXXX
KNOCK-OUT
Mouse
MXXXXX
NC4XXX
NCXXXX
NXXXXX
Serotonin-Deficient
VEXXXX
WIXXXX
Bookmark this page
Download as PDF
For Information, Contact:
Jennifer Wong
Technology Development Coordinator
NIH Technology Transfer
301-828-3707
jennifer.wong2@nih.gov